SC Ropharma (BSE:RPH) Beginning Cash Position: lei32 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:RPH SC Ropharma SA BSE:RPH
66 GF Score
Price lei0.22
View Full Analysis

What is SC Ropharma Beginning Cash Position?

SC Ropharma BSE:RPH -0.89% 66 Beginning Cash Position is lei32 Mil as of Dec. 2024. GuruFocus rates BSE:RPH with a GF Score™ of 66/100.

SC Ropharma's Beginning Cash Position for the quarter that ended in Dec. 2024 was lei32 Mil.

SC Ropharma's quarterly Beginning Cash Position declined from Dec. 2023 (lei28 Mil) to Jun. 2024 (lei17 Mil) but then increased from Jun. 2024 (lei17 Mil) to Dec. 2024 (lei32 Mil).

SC Ropharma's annual Beginning Cash Position increased from Dec. 2022 (lei11 Mil) to Dec. 2023 (lei15 Mil) and increased from Dec. 2023 (lei15 Mil) to Dec. 2024 (lei17 Mil).


SC Ropharma Beginning Cash Position Related Terms


SC Ropharma Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for SC Ropharma's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SC Ropharma Beginning Cash Position Chart

SC Ropharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.52 14.66 10.66 15.42 16.51

SC Ropharma Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.06 15.43 28.03 16.51 32.48
BSE:RPH
66GF Score
SC Ropharma SA BSE:RPH
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SC Ropharma Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of lei32 Mil mean?
SC Ropharma (BSE:RPH) has a Beginning Cash Position of lei32 Mil as of Dec. 2024. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on SC Ropharma and its competitors.
Is SC Ropharma's Beginning Cash Position too high?
SC Ropharma's current Beginning Cash Position is lei32 Mil. Overall, SC Ropharma has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does SC Ropharma's Beginning Cash Position compare to competitors?
SC Ropharma's Beginning Cash Position of lei32 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Healthcare Providers & Services company?
A good Beginning Cash Position depends on the Healthcare Providers & Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on SC Ropharma and its competitors. SC Ropharma's current Beginning Cash Position is lei32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SC Ropharma stock overvalued right now?
SC Ropharma (BSE:RPH) has a current Beginning Cash Position of lei32 Mil. The current Beginning Cash Position is lei32 Mil. SC Ropharma's overall GF Score™ is 66/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For SC Ropharma (BSE:RPH), the current Beginning Cash Position is lei32 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SC Ropharma Business Description

Address Strada Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.
66GF Score

Get the complete analysis for BSE:RPH

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.22
Price